Accelerated approval of semaglutide 7.2 mg establishes a higher-dose, once-weekly GLP-1 RA option for long-term weight ...

Tirzepatide vs. semaglutide, which is better? Medical experts agree that tirzepatide has better results, but the right drug ...

Semaglutide belongs to a class of medicines that act on GLP-1 receptors, which play a major role in appetite, digestion and ...

Oral semaglutide led to significant reductions in the risk for heart failure and major adverse cardiac events (MACEs) among patients with type 2 diabetes (T2D) with a history of heart failure, a ...

Weight management medications are transforming the landscape of obesity treatment, with semaglutide emerging as a groundbreaking solution for individuals struggling with weight loss. As demand surges ...

With semaglutide's patent expiry in India, cheaper generics may expand access to obesity and diabetes care. Experts weigh ...

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that was originally approved by the Food and Drug Administration (FDA) for the treatment of type 2 diabetes (T2D). Current research ...

The results of the EVOKE and EVOKE+ trials were comprehensive in showing oral semaglutide’s lack of clinical efficacy for ...

The use of semaglutide, a medication from the class of GLP-1 receptor agonists, has become increasingly popular. The brands Rybelsus and Ozempic are currently FDA-approved for diabetes management, and ...

Patients with type 2 diabetes and a baseline HbA1c greater than 7.0% experienced greater cardiovascular benefits while using oral semaglutide. Oral semaglutide elicits more pronounced cardiovascular ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Semaglutide — the active ingredient in the brand-name meds ...